Page 36 - Jabbed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Significant _ isn't it? yeah,. does it feel significant compared - isn't it? yeah,. does it feel significant compared to - isn't it? yeah,. does it feel. significant compared to what isn't it? yeah,. does it feel- significant compared to what is happening in ukraine? it has been a difficult two years for the travel industry and for families who want to get away, having to cancel holidays, delay them. it has been quite stressful. finally, a massive change, a big day for the industry. good morning. welcome back to the breakfast departure lounge. from four on friday all requirements for covid tes...

No need to wait until tomorrow morning to see what's in the papers - tune in for a lively and informed conversation about the next day's headlines.

England next month. we're already seeing businesses unable to function, hospitality businesses having to close. if i take nurseries for example, they have to maintain legal ratios of staff to children in order to stay open, and the early years sector has a young workforce, many of whom are not double vaccinated. so cases are skyrocketing and nurseries are being put in the position of having to turn families away in orderto maintain legal ratios. which families do you think they should be prioritising? we have to make sure that we use the tools we have to, in the form of isolation, to get throu...

Thejoint committee on vaccination and immunisation will recommend that 16 and 17—year—olds are given the jab. at the moment, only under—18s with underlying health conditions or living with someone vulnerable, qualify for the vaccine. here�*sjim reed. 46 million adults have already received a covid vaccine. now the jab is set to be routinely offered to under 18s for the first time. scientists on thejcvi are expected to recommend that all 16 and 17—year—olds should be next in line. throughout the pandemic we have listened to thejcvi, and we have adopted their recommendations because ...

Stephen Sackur speaks to Professor Sir Andrew Pollard, a key player in the development of the Oxford AstraZeneca Covid-19 vaccine.